内視鏡再処理市場規模、セグメント分析、2030年までの世界予測

Endoscope Reprocessing Market - Global Forecast to 2030

内視鏡再処理市場 - 製品(AER、HLDおよびテストストリップ、洗剤およびワイプ、内視鏡の乾燥・保管・輸送システム、追跡ソリューション)、内視鏡の種類(フレキシブル、リジッド)、エンドユーザー(病院、ASC、専門クリニック) - 2030年までの世界予測
Endoscope Reprocessing Market by Product (AER, HLD & Test Strip, Detergent & Wipe, Endoscope Drying, Storage, & Transport System, Tracking Solution), Endoscope Type (Flexible, Rigid), End User (Hospital, ASC, Specialty Clinic) - Global Forecast to 2030

商品番号 : SMB-3855

出版社MarketsandMarkets
出版年月2025年9月
ページ数298
図表数381
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

本レポートは、内視鏡再処理市場を製品、内視鏡の種類、エンドユーザー、地域別に分析しています。また、市場の成長に影響を与える推進要因、制約要因、機会、課題といった要因を考察し、市場リーダーの競争環境の詳細を提供しています。さらに、個々の成長傾向に基づいてミクロ市場を分析しています。本レポートは、5つの主要地域と各地域内の各国における市場セグメントの収益予測を示しています。

世界の内視鏡再処理市場は、予測期間中に9.4%のCAGRで成長し、2025年の27億1,000万米ドルから2030年には42億4,000万米ドルに達すると予測されています。

内視鏡再処理市場の世界的成長は、内視鏡手術件数の増加が主な牽引役であり、消化器系、呼吸器系、泌尿器系の疾患の罹患率の上昇と高齢化率の世界的な増加がそれを支えています。さらに、汚染された内視鏡や不適切な消毒を受けた内視鏡に起因する感染リスクへの意識の高まりから、医療機関はより厳格な再処理プロトコルを導入するようになり、高度な再処理ソリューションの需要がさらに高まっています。さらに、FDA、CDC、SGNAなどの世界の保健当局からの規制圧力とガイドラインの更新により、より安全で標準化された再処理方法が推奨されています。自動再処理システムの導入増加、医療インフラへの投資増加、そして患者の安全性向上に向けた世界的な取り組みも市場の成長を後押ししています。しかしながら、資本コストの高さや再処理ワークフローの複雑さといった課題が、特に資源の限られた地域では市場拡大を制限する可能性があります。

The global endoscope reprocessing market is projected to reach USD 4.24 billion by 2030 from USD 2.71 billion in 2025, at a CAGR of 9.4% during the forecast period.

The global endoscope reprocessing market growth is mainly driven by the increasing number of endoscopic procedures, supported by the rising prevalence of gastrointestinal, respiratory, and urological conditions, as well as the growing geriatric population worldwide. Additionally, increased awareness of infection risks linked to contaminated or improperly disinfected endoscopes has led healthcare facilities to implement stricter reprocessing protocols, further increasing the demand for advanced reprocessing solutions. Furthermore, regulatory pressures and updated guidelines from global health authorities such as the FDA, CDC, and SGNA are encouraging safer and more standardized reprocessing practices. The rising adoption of automated reprocessing systems, higher investments in healthcare infrastructure, and the worldwide effort to improve patient safety are also fueling market growth. However, challenges like high capital costs and the complexity of reprocessing workflows may limit market expansion, especially in resource-limited regions.

内視鏡再処理市場規模、セグメント分析、2030年までの世界予測
endoscope-reprocessing-market-Overview

The flexible endoscopes segment accounted for the largest market share in the endoscope reprocessing market in 2024.

The endoscope reprocessing market, by type of endoscope, is divided into flexible endoscopes and rigid endoscopes. In 2024, the flexible endoscopes segment led the market due to their widespread use in diagnostic and therapeutic procedures across gastroenterology, pulmonology, and urology. These scopes are favored because of their ability to access difficult-to-reach anatomical areas and provide greater patient comfort. The rising number of routine and advanced procedures, such as colonoscopies and bronchoscopies, which mainly use flexible scopes, has further increased the demand for effective reprocessing solutions to ensure safety and prevent cross-contamination. Additionally, regulatory focus on strict cleaning standards for complex devices like duodenoscopes is strengthening the adoption of reprocessing systems designed for flexible endoscopes.

The hospitals & ambulatory surgery centers segment commanded the largest market share in 2024 and is expected to witness the highest CAGR from 2025 to 2030.

By end user, the endoscope reprocessing market is segmented into hospitals & ambulatory surgery centers, specialty clinics, and other end users. The hospitals and ambulatory surgery centers segment holds the largest share of the endoscope reprocessing market in 2024 and is expected to grow faster during the forecast period, driven by the high volume of endoscopy procedures in these settings. Its growth is supported by factors such as the availability of advanced infrastructure, increased funding for infection prevention, and the adoption of automated reprocessing equipment to meet regulatory and accreditation standards. Furthermore, as hospitals seek to reduce healthcare-associated infections (HAIs) and comply with updated reprocessing protocols, the need for compliant and efficient systems is rapidly increasing. ASCs, offering cost savings and shorter patient turnaround times, are also experiencing a rise in endoscopic procedures, boosting the demand for high-throughput reprocessing solutions.

Europe accounted for the second-largest share of the endoscope reprocessing market by region in 2024.

The global endoscope reprocessing market is divided into five main regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Europe’s endoscope reprocessing market is the second-largest regional market. This strong position is supported by robust healthcare infrastructure, regulatory enforcement on infection control, and the increasing burden of chronic diseases that require frequent endoscopic procedures and examinations. Among the European countries, Germany has the largest share, driven by its growing elderly population and increasing surgical procedures. According to the United Nations Population Division, Germany’s population aged 65 and older is expected to increase by 41%, reaching roughly 24 million by 2050, which will be about 30% of the total population. Additionally, the Financial Times reports that by 2050, more than half of Germany’s population will be aged 48 and older, with nearly a third exceeding 60 years. This demographic change is leading to a rise in age-related gastrointestinal, orthopedic, and cardiovascular conditions, resulting in greater demand for endoscopic procedures and boosting the need for advanced and reliable endoscope reprocessing systems to ensure infection control and safety standards.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1- 40%, Tier 2- 30%, and Tier 3- 30%
  • By Designation: C Level- 27%, Director Level- 18% and Others- 55%
  • By Region: North America- 35%, Europe- 30%, Asia Pacific- 22%, Latin America- 10%, and Middle East & Africa- 3%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the endoscope reprocessing market are STERIS (Ireland), ASP (US), Olympus Corporation (Japan), Ecolab (US), Getinge AB (Sweden), HOYA Corporation (Japan), Conmed Corporation (US), Miele (Germany), Endo-Technik W. Griesat GmbH (UK), Fujifilm Holdings Corporation (Japan), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), and Metrex Research, LLC. (Canada), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), Medonica Co., Ltd. (South Korea), Shinva Medical Instrument Co., Ltd. (China), Micro-Scientific, LLC (US), Medalkan (Greece), Medical Devices Group Srl (Italy), SBSystem (Italy), Olive Health Care (India), MMM Group (Germany), Amity International (UK), and MİXTA MEDİKAL (Turkey), among others.

Research Coverage

This report examines the endoscope reprocessing market by products, type of endoscope, end user, and region. The report also explores factors such as drivers, restraints, opportunities, and challenges that influence market growth and provides details of the competitive landscape for market leaders. Additionally, it analyzes micro markets based on their individual growth trends. The report forecasts the revenue of market segments across five major regions and the respective countries within those regions.

Reasons to Buy the Report

The report will help both established and smaller firms to understand the market trends, which can then assist them in increasing their market share. Companies purchasing the report may use one or a combination of the strategies listed below to strengthen their market position presence.

This report provides insights on the following points: analysis of key drivers (rising demand for endoscopy to diagnose and treat target diseases, elevated risk of endoscope-associated infections, expanding aging population, increasing emphasis on improving reprocessing guidelines by healthcare authorities, and rising adoption of minimally invasive surgeries), restraints (persistent concerns regarding safety and effectiveness of reprocessed endoscopic devices, potential health hazards associated with exposure to high-level chemical disinfectants, and high operational costs of endoscopic procedures coupled with limited reimbursement frameworks in emerging economies), opportunities (expanding medical devices industry in emerging economies and increased funding and investments for better healthcare infrastructure and endoscopy-related research), and challenges (rising demand for single-use endoscopes, increasing product failures and recalls, lack of adequately trained personnel, limited awareness among healthcare workers regarding standardized and effective reprocessing practices, and increasing FDA recommended measures to reduce infection transmission)

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the endoscope reprocessing market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the endoscope reprocessing market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the endoscope reprocessing market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

Table of Contents

1               INTRODUCTION              28

1.1           STUDY OBJECTIVES       28

1.2           MARKET DEFINITION   28

1.3           STUDY SCOPE   29

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 29

1.3.2        INCLUSIONS AND EXCLUSIONS 30

1.3.3        YEARS CONSIDERED      30

1.4           CURRENCY CONSIDERED            31

1.5           STAKEHOLDERS               31

1.6           SUMMARY OF CHANGES               31

2               RESEARCH METHODOLOGY       33

2.1           RESEARCH DATA              33

2.1.1        SECONDARY DATA          34

2.1.1.1    List of key secondary sources              34

2.1.1.2    Key data from secondary sources       35

2.1.2        PRIMARY DATA 35

2.1.2.1    Key primary sources             36

2.1.2.2    Key objectives of primary research    36

2.1.2.3    Key data from primary sources           37

2.1.2.4    Key industry insights           38

2.1.2.5    Breakdown of primary interviews      38

2.2           MARKET SIZE ESTIMATION         39

2.2.1        BOTTOM-UP APPROACH              39

2.2.1.1    Company revenue estimation approach            40

2.2.1.1.1 Presentations of companies and primary interviews       40

2.2.1.1.2 Primary interviews                41

2.2.1.2    Growth forecast    41

2.2.1.3    Market segment assessment                42

2.2.2        TOP-DOWN APPROACH                42

2.3           DATA TRIANGULATION                43

2.4           MARKET SHARE ANALYSIS           44

2.5           RESEARCH ASSUMPTIONS           44

2.5.1        PARAMETRIC ASSUMPTIONS     44

2.5.2        GROWTH RATE ASSUMPTIONS 44

2.6           RESEARCH LIMITATIONS             45

2.6.1        METHODOLOGY-RELATED LIMITATIONS           45

2.6.2        SCOPE-RELATED LIMITATIONS                 45

2.7           RISK ANALYSIS  45

3               EXECUTIVE SUMMARY  46

4               PREMIUM INSIGHTS       50

4.1           ENDOSCOPE REPROCESSING MARKET OVERVIEW                 50

4.2           ASIA PACIFIC ENDOSCOPE REPROCESSING MARKET,  BY PRODUCT AND COUNTRY    51

4.3           ENDOSCOPE REPROCESSING MARKET, BY COUNTRY                 52

4.4           ENDOSCOPE REPROCESSING MARKET, REGIONAL MIX,  2025 VS. 2030       53

4.5           ENDOSCOPE REPROCESSING MARKET:  EMERGING ECONOMIES VS. DEVELOPED MARKETS                54

5               MARKET OVERVIEW       55

5.1           INTRODUCTION              55

5.2           MARKET DYNAMICS       55

5.2.1        DRIVERS               56

5.2.1.1    Rising demand for endoscopy to diagnose and treat target diseases  56

5.2.1.2    Elevated risk of endoscope-associated infections            56

5.2.1.3    Booming geriatric population             57

5.2.1.4    Increasing emphasis on improving reprocessing guidelines                 58

5.2.1.5    Growing adoption of minimally invasive surgeries          59

5.2.2        RESTRAINTS      59

5.2.2.1    Persistent concerns about safety and effectiveness of reprocessed endoscopic devices               59

5.2.2.2    Potential health hazards associated with exposure to high-level chemical disinfectants          60

5.2.2.3    High operational costs and limited reimbursement in developing economies              60

5.2.3        OPPORTUNITIES              61

5.2.3.1    Expanding medical devices industry 61

5.2.3.2    Increased funding and investments for healthcare infrastructure                 61

5.2.4        CHALLENGES    62

5.2.4.1    Preference for single-use endoscopes                62

5.2.4.2    Increasing number of product failures and recalls          62

5.2.4.3    Lack of adequately trained personnel                63

5.2.4.4    Limited awareness about standardized and effective reprocessing practices 63

5.2.4.5    Increasing FDA-recommended measures to reduce infection transmission          64

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            64

5.4           PRICING ANALYSIS          65

5.4.1        AVERAGE SELLING PRICE TREND, BY KEY PLAYER                 65

5.4.2        AVERAGE SELLING PRICE TREND, BY REGION   66

5.5           VALUE CHAIN ANALYSIS               67

5.6           SUPPLY CHAIN ANALYSIS             68

5.7           ECOSYSTEM ANALYSIS  69

5.8           INVESTMENT AND FUNDING SCENARIO               71

5.9           TECHNOLOGY ANALYSIS             72

5.9.1        KEY TECHNOLOGIES     72

5.9.1.1    Automated mechanical cleaning and disinfection           72

5.9.1.2    High-level chemical disinfection        72

5.9.2        COMPLEMENTARY TECHNOLOGIES       72

5.9.2.1    Low-temperature sterilization            72

5.10         PATENT ANALYSIS          73

5.11         TRADE ANALYSIS             75

5.11.1      IMPORT DATA FOR HS CODE 841920       75

5.11.2      EXPORT DATA FOR HS CODE 841920       75

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        76

5.13         REGULATORY ANALYSIS               77

5.13.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             77

5.13.2      REGULATORY FRAMEWORK       79

5.13.2.1  North America      79

5.13.2.1.1                US           79

5.13.2.1.2                Canada   79

5.13.2.2  Europe   79

5.13.2.2.1                Germany                 79

5.13.2.2.2                Rest of Europe      80

5.13.2.3  Asia Pacific            80

5.13.2.3.1                Japan      80

5.13.2.3.2                Australia 80

5.13.2.3.3                Rest of Asia Pacific               80

5.13.2.4  Latin America       81

5.13.2.5  Middle East & Africa            81

5.14         PORTER’S FIVE FORCES ANALYSIS           81

5.14.1      THREAT OF NEW ENTRANTS      82

5.14.2      THREAT OF SUBSTITUTES          82

5.14.3      BARGAINING POWER OF BUYERS             83

5.14.4      BARGAINING POWER OF SUPPLIERS       83

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 83

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     83

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           84

5.15.2      KEY BUYING CRITERIA  84

5.16         IMPACT OF AI/GEN AI ON ENDOSCOPE REPROCESSING MARKET               85

5.16.1      INTRODUCTION              85

5.16.2      MARKET POTENTIAL OF AI/GEN AI IN ENDOSCOPE REPROCESSING MARKET              85

5.16.3      AI USE CASES     86

5.16.4      FUTURE OF AI/GEN AI IN ENDOSCOPE REPROCESSING ECOSYSTEM       86

5.17         IMPACT OF 2025 US TARIFF REGULATION ON ENDOSCOPE REPROCESSING MARKET  87

5.17.1      INTRODUCTION              87

5.17.2      KEY TARIFF RATES          87

5.17.3      PRICE IMPACT ANALYSIS             88

5.17.4      KEY IMPACT ON COUNTRY/REGION      88

5.17.4.1  North America      88

5.17.4.1.1                US           88

5.17.4.2  Europe   88

5.17.4.3  Asia Pacific            88

5.17.5      IMPACT ON END-USE INDUSTRIES          89

5.17.5.1  Hospitals                89

5.17.5.2  Ambulatory care centers      89

6               ENDOSCOPE REPROCESSING MARKET, BY PRODUCT                 90

6.1           INTRODUCTION              91

6.2           ENDOSCOPE REPROCESSING EQUIPMENT          91

6.2.1        AUTOMATED ENDOSCOPE REPROCESSORS        94

6.2.1.1    Automated endoscope reprocessors, by portability         98

6.2.1.1.1 Standalone automated endoscope reprocessors               98

6.2.1.1.2 Portable automated endoscope reprocessors   101

6.2.1.2    Automated endoscope reprocessors, by type   103

6.2.1.2.1 Single-basin automated endoscope reprocessors             104

6.2.1.2.2 Double-basin automated endoscope reprocessors          107

6.2.2        ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS              110

6.2.2.1    Need for patient safety and efficient reprocessing workflow to accelerate growth 110

6.3           ENDOSCOPE REPROCESSING CONSUMABLES    114

6.3.1        DETERGENTS & WIPES  117

6.3.1.1    Rising focus on pre-cleaning protocols to aid growth     117

6.3.2        HIGH-LEVEL DISINFECTANTS & TEST STRIPS     120

6.3.2.1    Growing number of infection outbreaks to drive market                 120

6.3.3        OTHER PRODUCTS         123

6.4           ENDOSCOPE TRACKING SOLUTIONS     127

6.4.1        IMPROVED TRACEABILITY AND SUPERVISION TO FOSTER GROWTH            127

7               ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE      131

7.1           INTRODUCTION              132

7.2           FLEXIBLE ENDOSCOPES               132

7.2.1        REAL-TIME IMAGING CAPABILITIES TO CONTRIBUTE TO GROWTH     132

7.3           RIGID ENDOSCOPES      135

7.3.1        SUPERIOR IMAGE RESOLUTION AND ENHANCED STABILITY TO SPUR GROWTH   135

8               ENDOSCOPE REPROCESSING MARKET, BY END USER                 139

8.1           INTRODUCTION              140

8.2           HOSPITALS & ASCS          140

8.2.1        RISE IN INFECTION CASES TO FACILITATE GROWTH                 140

8.3           SPECIALTY CLINICS        144

8.3.1        NEED TO MAINTAIN HIGH STANDARDS OF SAFETY AND QUALITY TO FOSTER GROWTH                 144

8.4           OTHER END USERS         146

9               ENDOSCOPE REPROCESSING MARKET, BY REGION                 150

9.1           INTRODUCTION              151

9.2           NORTH AMERICA             151

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 151

9.2.2        US           156

9.2.2.1    Rising incidence of colorectal cancer to augment growth                 156

9.2.3        CANADA               160

9.2.3.1    High prevalence of hospital-acquired infections to promote growth    160

9.3           EUROPE               164

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      164

9.3.2        GERMANY           168

9.3.2.1    Aging population and increasing disease burden to support growth    168

9.3.3        UK          171

9.3.3.1    Increasing use of endoscopy procedures to foster growth                 171

9.3.4        FRANCE                175

9.3.4.1    Strong public investment in healthcare infrastructure to aid growth    175

9.3.5        ITALY    178

9.3.5.1    Growing geriatric population to drive market 178

9.3.6        SPAIN    181

9.3.6.1    Demographic shift and increasing number of specialized care personnel to expedite growth              181

9.3.7        REST OF EUROPE             184

9.4           ASIA PACIFIC     188

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 189

9.4.2        JAPAN   192

9.4.2.1    Increasing number of endoscopic surgeries to spur growth                 192

9.4.3        CHINA  195

9.4.3.1    Rising elderly population to facilitate growth  195

9.4.4        INDIA    198

9.4.4.1    Improved healthcare infrastructure and booming healthcare tourism to bolster growth    198

9.4.5        AUSTRALIA         201

9.4.5.1    Growing number of age-related illnesses to boost market                 201

9.4.6        REST OF ASIA PACIFIC   204

9.5           LATIN AMERICA                207

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 208

9.5.2        BRAZIL 211

9.5.2.1    Need to maintain hygiene and safety standards to boost market                 211

9.5.3        MEXICO                214

9.5.3.1    Rising cancer burden to accelerate growth       214

9.5.4        REST OF LATIN AMERICA             217

9.6           MIDDLE EAST & AFRICA                220

9.6.1        EMERGING STANDARDS FOR REPROCESSING TO AUGMENT GROWTH      220

10            COMPETITIVE LANDSCAPE         225

10.1         INTRODUCTION              225

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            225

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET             225

10.3         REVENUE ANALYSIS, 2020–2024  227

10.4         MARKET SHARE ANALYSIS, 2024                 228

10.5         COMPANY VALUATION AND FINANCIAL METRICS                 230

10.6         BRAND/PRODUCT COMPARISON             231

10.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 231

10.7.1      STARS   231

10.7.2      EMERGING LEADERS     231

10.7.3      PERVASIVE PLAYERS      232

10.7.4      PARTICIPANTS 232

10.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         233

10.7.5.1  Company footprint               233

10.7.5.2  Region footprint   233

10.7.5.3  Product footprint  234

10.7.5.4  End-user footprint                234

10.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        235

10.8.1      PROGRESSIVE COMPANIES         235

10.8.2      RESPONSIVE COMPANIES            235

10.8.3      DYNAMIC COMPANIES  235

10.8.4      STARTING BLOCKS         235

10.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 237

10.8.5.1  Detailed list of key startups/SMEs    237

10.8.5.2  Competitive benchmarking of key startups/SMEs          237

10.9         COMPETITIVE SCENARIO             238

10.9.1      PRODUCT LAUNCHES   238

10.9.2      DEALS  239

10.9.3      EXPANSIONS     240

10.9.4      OTHER DEVELOPMENTS              240

11            COMPANY PROFILES      241

11.1         KEY PLAYERS     241

11.1.1      STERIS  241

11.1.1.1  Business overview 241

11.1.1.2  Products offered   242

11.1.1.3  MnM view              246

11.1.1.3.1                Key strengths        246

11.1.1.3.2                Strategic choices   246

11.1.1.3.3                Weaknesses and competitive threats 246

11.1.2      ASP         247

11.1.2.1  Business overview 247

11.1.2.2  Products offered   248

11.1.2.3  MnM view              249

11.1.2.3.1                Key strengths        249

11.1.2.3.2                Strategic choices   249

11.1.2.3.3                Weaknesses and competitive threats 249

11.1.3      OLYMPUS CORPORATION           250

11.1.3.1  Business overview 250

11.1.3.2  Products offered   251

11.1.3.3  Recent developments           253

11.1.3.3.1                Product launches  253

11.1.3.3.2                Expansions             253

11.1.3.4  MnM view              254

11.1.3.4.1                Key strengths        254

11.1.3.4.2                Strategic choices   254

11.1.3.4.3                Weaknesses and competitive threats 254

11.1.4      GETINGE AB      255

11.1.4.1  Business overview 255

11.1.4.2  Products offered   256

11.1.4.3  Recent developments           258

11.1.4.3.1                Product launches  258

11.1.4.3.2                Deals      258

11.1.5      ECOLAB INC.     259

11.1.5.1  Business overview 259

11.1.5.2  Products offered   260

11.1.5.3  Recent developments           261

11.1.5.3.1                Other developments             261

11.1.6      HOYA CORPORATION   262

11.1.6.1  Business overview 262

11.1.6.2  Products offered   263

11.1.6.3  Recent developments           265

11.1.6.3.1                Deals      265

11.1.7      CONMED CORPORATION             266

11.1.7.1  Business overview 266

11.1.7.2  Products offered   268

11.1.8      THE MIELE GROUP         269

11.1.8.1  Business overview 269

11.1.8.2  Products offered   269

11.1.8.3  Recent developments           270

11.1.8.3.1                Deals      270

11.1.9      ARC HEALTHCARE SOLUTIONS 271

11.1.9.1  Business overview 271

11.1.9.2  Products offered   271

11.1.10   METREX RESEARCH, LLC              273

11.1.10.1                 Business overview 273

11.1.10.2                 Products offered   273

11.2         OTHER PLAYERS              274

11.2.1      MEDALKAN        274

11.2.2      MICRO-SCIENTIFIC, LLC               275

11.2.3      ENDO-TECHNIK W. GRIESAT GMBH        276

11.2.4      BES HEALTHCARE LTD 277

11.2.5      FUJIFILM HOLDINGS CORPORATION     278

11.2.6      BORER CHEMIE AG         279

11.2.7      MEDONICA CO. LTD       280

11.2.8      TUTTNAUER      281

11.2.9      SHINVA MEDICAL INSTRUMENT CO., LTD.          282

11.2.10   SBSYSTEM           283

11.2.11   OLIVE HEALTH CARE     284

11.2.12   MMM GROUP    285

11.2.13   AMITY INTERNATIONAL               286

11.2.14   MİXTA MEDİKAL              287

11.2.15   MEDICAL DEVICES GROUP SRL 288

12            APPENDIX           289

12.1         DISCUSSION GUIDE        289

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL                294

12.3         CUSTOMIZATION OPTIONS        296

12.4         RELATED REPORTS         296

12.5         AUTHOR DETAILS           297

LIST OF TABLES

TABLE 1                ENDOSCOPE REPROCESSING MARKET: INCLUSIONS AND EXCLUSIONS 30

TABLE 2                EXCHANGE RATES USED FOR CONVERSION OF YEN TO USD, 2023–2025  31

TABLE 3                EXCHANGE RATES USED FOR CONVERSION OF SEK TO USD, 2022–2024  31

TABLE 4                ENDOSCOPE REPROCESSING MARKET: KEY DATA FROM PRIMARY SOURCES               37

TABLE 5                ENDOSCOPE REPROCESSING MARKET: PARAMETRIC ASSUMPTIONS     44

TABLE 6                ENDOSCOPE REPROCESSING MARKET: RISK ANALYSIS            45

TABLE 7                AVERAGE SELLING PRICE TREND OF ENDOSCOPE REPROCESSING DEVICES,

BY KEY PLAYER, 2022–2024 (USD)              66

TABLE 8                AVERAGE SELLING PRICE TREND OF ENDOSCOPE REPROCESSING DEVICES,

BY REGION, 2022–2024 (USD)      66

TABLE 9                ENDOSCOPE REPROCESSING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 70

TABLE 10              ENDOSCOPE REPROCESSING MARKET: LIST OF PATENTS/PATENT REGISTRATIONS, 2023–2024  74

TABLE 11              IMPORT DATA FOR HS CODE 841920, BY COUNTRY,

2020–2024 (USD THOUSAND)      75

TABLE 12              EXPORT DATA FOR HS CODE 841920, BY COUNTRY,

2020–2024 (USD THOUSAND)      75

TABLE 13              ENDOSCOPE REPROCESSING MARKET: KEY CONFERENCES AND EVENTS,

2025–2026              76

TABLE 14              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 77

TABLE 15              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           77

TABLE 16              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 78

TABLE 17              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 78

TABLE 18              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 78

TABLE 19              ENDOSCOPE REPROCESSING MARKET: PORTER’S FIVE FORCES 81

TABLE 20              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)      84

TABLE 21              KEY BUYING CRITERIA, BY END USER    85

TABLE 22              US ADJUSTED RECIPROCAL TARIFF RATES                 87

TABLE 23              ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     91

TABLE 24              ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            92

TABLE 25              ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY REGION,

2023–2030 (USD MILLION)            92

TABLE 26              NORTH AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 93

TABLE 27              EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            93

TABLE 28              ASIA PACIFIC: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 94

TABLE 29              LATIN AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 94

TABLE 30              MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS       95

TABLE 31              AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION,

2023–2030 (USD MILLION)            96

TABLE 32              NORTH AMERICA: AUTOMATED ENDOSCOPE RREPROCESSORS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               96

TABLE 33              EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            97

TABLE 34              ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            97

TABLE 35              LATIN AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               98

TABLE 36              AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY,

2023–2030 (USD MILLION)            98

TABLE 37              STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION)                 99

TABLE 38              NORTH AMERICA: STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99

TABLE 39              EUROPE: STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               100

TABLE 40              ASIA PACIFIC: STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100

TABLE 41              LATIN AMERICA: STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101

TABLE 42              PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION)                 101

TABLE 43              NORTH AMERICA: PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102

TABLE 44              EUROPE: PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               102

TABLE 45              ASIA PACIFIC: PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               103

TABLE 46              LATIN AMERICA: PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103

TABLE 47              AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            104

TABLE 48              MANUFACTURERS AND RESPECTIVE SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSOR MODELS                 104

TABLE 49              SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION)                 105

TABLE 50              NORTH AMERICA: SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105

TABLE 51              EUROPE: SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               106

TABLE 52              ASIA PACIFIC: SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106

TABLE 53              LATIN AMERICA: SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107

TABLE 54              MANUFACTURERS AND RESPECTIVE DUAL-BASIN AUTOMATED ENDOSCOPE REPROCESSOR MODELS                 107

TABLE 55              DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION)                 108

TABLE 56              NORTH AMERICA: DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     108

TABLE 57              EUROPE: DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               109

TABLE 58              ASIA PACIFIC: DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109

TABLE 59              LATIN AMERICA: DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110

TABLE 60              ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS OFFERED

BY KEY PLAYERS               111

TABLE 61              ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)            112

TABLE 62              NORTH AMERICA: ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            112

TABLE 63              EUROPE: ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               113

TABLE 64              ASIA PACIFIC: ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113

TABLE 65              LATIN AMERICA: ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            114

TABLE 66              ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            114

TABLE 67              ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY REGION,

2023–2030 (USD MILLION)            115

TABLE 68              NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               115

TABLE 69              EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            116

TABLE 70              ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               116

TABLE 71              LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               117

TABLE 72              ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY REGION, 2023–2030 (USD MILLION) 118

TABLE 73              NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY COUNTRY, 2023–2030 (USD MILLION)     118

TABLE 74              EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY COUNTRY, 2023–2030 (USD MILLION)     119

TABLE 75              ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY COUNTRY, 2023–2030 (USD MILLION)     119

TABLE 76              LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY COUNTRY, 2023–2030 (USD MILLION)     120

TABLE 77              ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY REGION, 2023–2030 (USD MILLION)          121

TABLE 78              NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY COUNTRY,

2023–2030 (USD MILLION)            121

TABLE 79              EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY COUNTRY, 2023–2030 (USD MILLION)  122

TABLE 80              ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY COUNTRY, 2023–2030 (USD MILLION)  122

TABLE 81              LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY COUNTRY, 2023–2030 (USD MILLION)  123

TABLE 82              OTHER REPROCESSING CONSUMABLE PRODUCTS OFFERED BY MANUFACTURERS       124

TABLE 83              ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS,

BY REGION, 2023–2030 (USD MILLION)   125

TABLE 84              NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)            125

TABLE 85              EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)            126

TABLE 86              ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)            126

TABLE 87              LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION)            127

TABLE 88              ENDOSCOPE TRACKING SOLUTIONS MARKET, BY REGION,

2023–2030 (USD MILLION)            128

TABLE 89              NORTH AMERICA: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 128

TABLE 90              EUROPE: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            129

TABLE 91              ASIA PACIFIC: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            129

TABLE 92              LATIN AMERICA: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 130

TABLE 93              ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            132

TABLE 94              ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY REGION, 2023–2030 (USD MILLION)                 133

TABLE 95              NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 133

TABLE 96              EUROPE: ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES,

BY COUNTRY, 2023–2030 (USD MILLION)               134

TABLE 97              ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 134

TABLE 98              LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 135

TABLE 99              ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES, BY REGION, 2023–2030 (USD MILLION)                 136

TABLE 100            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 136

TABLE 101            EUROPE: ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 102            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 103            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 138

TABLE 104            ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION)                140

TABLE 105            HOSPITALS PER CAPITA, BY COUNTRY, 2024                 141

TABLE 106            ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS, BY REGION, 2023–2030 (USD MILLION)                 141

TABLE 107            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION)            142

TABLE 108            EUROPE: ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS,

BY COUNTRY, 2023–2030 (USD MILLION)               142

TABLE 109            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS,

BY COUNTRY, 2023–2030 (USD MILLION)               143

TABLE 110            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION)            143

TABLE 111            ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS, BY REGION, 2023–2030 (USD MILLION)                 144

TABLE 112            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 145

TABLE 113            EUROPE: ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               145

TABLE 114            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               146

TABLE 115            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 146

TABLE 116            ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)                 147

TABLE 117            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)            147

TABLE 118            EUROPE: ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 119            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 120            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)            149

TABLE 121            ENDOSCOPE REPROCESSING MARKET, BY REGION, 2023–2030 (USD MILLION)          151

TABLE 122            NORTH AMERICA: KEY MACROECONOMIC INDICATORS      151

TABLE 123            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 124            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            153

TABLE 125            NORTH AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)                 154

TABLE 126            NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 154

TABLE 127            NORTH AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY PORTABILITY, 2023–2030 (USD MILLION)       155

TABLE 128            NORTH AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 155

TABLE 129            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION)                 156

TABLE 130            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            156

TABLE 131            MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2025   157

TABLE 132            US: INSTALLATION BASE OF AUTOMATED ENDOSCOPE REPROCESSORS IN HOSPITALS, 2023–2030 (UNITS)                 158

TABLE 133            US: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            158

TABLE 134            US: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            158

TABLE 135            US: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            159

TABLE 136            US: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY,

2023–2030 (USD MILLION)            159

TABLE 137            US: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            159

TABLE 138            US: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            160

TABLE 139            US: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            160

TABLE 140            CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            161

TABLE 141            CANADA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            161

TABLE 142            CANADA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            162

TABLE 143            CANADA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            162

TABLE 144            CANADA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            162

TABLE 145            CANADA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            163

TABLE 146            CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            163

TABLE 147            EUROPE: KEY MACROECONOMIC INDICATORS                 164

TABLE 148          EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            165

TABLE 149          EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            165

TABLE 150            EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            166

TABLE 151            EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            166

TABLE 152            EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            167

TABLE 153            EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            167

TABLE 154          EUROPE: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            167

TABLE 155          EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            168

TABLE 156            GERMANY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            169

TABLE 157            GERMANY: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            169

TABLE 158            GERMANY: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 170

TABLE 159            GERMANY: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            170

TABLE 160            GERMANY: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            170

TABLE 161            GERMANY: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION)                 171

TABLE 162            GERMANY: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            171

TABLE 163            UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            172

TABLE 164            UK: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            173

TABLE 165            UK: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            173

TABLE 166            UK: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY,

2023–2030 (USD MILLION)            173

TABLE 167            UK: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            174

TABLE 168            UK: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            174

TABLE 169            UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            174

TABLE 170          FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            176

TABLE 171            FRANCE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            176

TABLE 172            FRANCE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            177

TABLE 173            FRANCE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            177

TABLE 174            FRANCE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            177

TABLE 175          FRANCE: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            178

TABLE 176          FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            178

TABLE 177            ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            179

TABLE 178            ITALY: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            179

TABLE 179            ITALY: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            180

TABLE 180            ITALY: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            180

TABLE 181            ITALY: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            180

TABLE 182            ITALY: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            181

TABLE 183            ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            181

TABLE 184            SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            182

TABLE 185            SPAIN: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            182

TABLE 186            SPAIN: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            183

TABLE 187            SPAIN: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            183

TABLE 188            SPAIN: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            183

TABLE 189            SPAIN: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            184

TABLE 190            SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            184

TABLE 191            REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            185

TABLE 192            REST OF EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)                 185

TABLE 193            REST OF EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         186

TABLE 194            REST OF EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY PORTABILITY, 2023–2030 (USD MILLION)       186

TABLE 195            REST OF EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 186

TABLE 196            REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION)                 187

TABLE 197            REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            187

TABLE 198            ASIA PACIFIC: KEY MACROECONOMIC INDICATORS      189

TABLE 199            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 200            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            190

TABLE 201            ASIA PACIFIC: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            190

TABLE 202            ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 191

TABLE 203            ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY PORTABILITY, 2023–2030 (USD MILLION)       191

TABLE 204            ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 191

TABLE 205            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION)                 192

TABLE 206            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            192

TABLE 207            JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            193

TABLE 208            JAPAN: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            193

TABLE 209            JAPAN: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            194

TABLE 210            JAPAN: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            194

TABLE 211            JAPAN: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            194

TABLE 212            JAPAN: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            195

TABLE 213            JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            195

TABLE 214            CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            196

TABLE 215            CHINA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            196

TABLE 216            CHINA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            197

TABLE 217            CHINA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            197

TABLE 218            CHINA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            197

TABLE 219            CHINA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            198

TABLE 220            CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            198

TABLE 221            INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            199

TABLE 222            INDIA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            199

TABLE 223            INDIA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            200

TABLE 224            INDIA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            200

TABLE 225            INDIA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            200

TABLE 226            INDIA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            201

TABLE 227            INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            201

TABLE 228            AUSTRALIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            202

TABLE 229            AUSTRALIA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            202

TABLE 230            AUSTRALIA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 203

TABLE 231            AUSTRALIA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            203

TABLE 232            AUSTRALIA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            203

TABLE 233            AUSTRALIA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION)                 204

TABLE 234            AUSTRALIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            204

TABLE 235            REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            205

TABLE 236            REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING EQUIPMENT MARKET,

BY TYPE, 2023–2030 (USD MILLION)         205

TABLE 237            REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         206

TABLE 238            REST OF ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY PORTABILITY, 2023–2030 (USD MILLION)       206

TABLE 239            REST OF ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         206

TABLE 240            REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,

BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION)       207

TABLE 241            REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,

BY END USER, 2023–2030 (USD MILLION)               207

TABLE 242            LATIN AMERICA: KEY MACROECONOMIC INDICATORS      208

TABLE 243            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            208

TABLE 244            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            209

TABLE 245            LATIN AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)                 209

TABLE 246            LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 210

TABLE 247            LATIN AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY PORTABILITY, 2023–2030 (USD MILLION)       210

TABLE 248            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE,

2023–2030 (USD MILLION)            210

TABLE 249            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION)                 211

TABLE 250            LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            211

TABLE 251            BRAZIL: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            212

TABLE 252            BRAZIL: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            212

TABLE 253            BRAZIL: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            213

TABLE 254            BRAZIL: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            213

TABLE 255            BRAZIL: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            213

TABLE 256            BRAZIL: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            214

TABLE 257            BRAZIL: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            214

TABLE 258          MEXICO: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            215

TABLE 259            MEXICO: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            215

TABLE 260            MEXICO: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            216

TABLE 261            MEXICO: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION)            216

TABLE 262            MEXICO: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE,

2023–2030 (USD MILLION)            216

TABLE 263          MEXICO: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2023–2030 (USD MILLION)            217

TABLE 264          MEXICO: ENDOSCOPE REPROCESSING MARKET, BY END USER,

2023–2030 (USD MILLION)            217

TABLE 265            REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            218

TABLE 266            REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET,

BY TYPE, 2023–2030 (USD MILLION)         218

TABLE 267            REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 219

TABLE 268            REST OF LATIN AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY PORTABILITY, 2023–2030 (USD MILLION)       219

TABLE 269            REST OF LATIN AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         219

TABLE 270            REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 220

TABLE 271            REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION)            220

TABLE 272            MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            221

TABLE 273            MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET,

BY TYPE, 2023–2030 (USD MILLION)         221

TABLE 274            MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222

TABLE 275            MIDDLE EAST & AFRICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY PORTABILITY, 2023–2030 (USD MILLION)       222

TABLE 276            MIDDLE EAST & AFRICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         222

TABLE 277            MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 223

TABLE 278            MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION)            223

TABLE 279            MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS              223

TABLE 280            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET, JANUARY 2022–JULY 2025  225

TABLE 281            ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION           228

TABLE 282            ENDOSCOPE REPROCESSING MARKET: REGION FOOTPRINT       233

TABLE 283            ENDOSCOPE REPROCESSING MARKET: PRODUCT FOOTPRINT 234

TABLE 284            ENDOSCOPE REPROCESSING MARKET: END-USER FOOTPRINT            234

TABLE 285            ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUPS/SMES             237

TABLE 286            ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES                 237

TABLE 287            ENDOSCOPE REPROCESSING MARKET: PRODUCT LAUNCHES,

JANUARY 2022–JULY 2025               238

TABLE 288            ENDOSCOPE REPROCESSING MARKET: DEALS, JANUARY 2022–JULY 2025               239

TABLE 289            ENDOSCOPE REPROCESSING MARKET: EXPANSIONS, JANUARY 2022–JULY 2025  240

TABLE 290            ENDOSCOPE REPROCESSING MARKET: OTHER DEVELOPMENTS,

JANUARY 2022–JULY 2025               240

TABLE 291            STERIS: COMPANY OVERVIEW   241

TABLE 292            STERIS: PRODUCTS OFFERED    242

TABLE 293            ASP: COMPANY OVERVIEW         247

TABLE 294            ASP: PRODUCTS OFFERED          248

TABLE 295            OLYMPUS CORPORATION: COMPANY OVERVIEW          250

TABLE 296            OLYMPUS CORPORATION: PRODUCTS OFFERED             251

TABLE 297            OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025     253

TABLE 298            OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025               253

TABLE 299            GETINGE AB: COMPANY OVERVIEW       255

TABLE 300            GETINGE AB: PRODUCTS OFFERED        256

TABLE 301            GETINGE AB: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025  258

TABLE 302            GETINGE AB: DEALS, JANUARY 2022–JULY 2025                 258

TABLE 303            ECOLAB INC.: COMPANY OVERVIEW      259

TABLE 304            ECOLAB INC.: PRODUCTS OFFERED       260

TABLE 305            ECOLAB INC.: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025               261

TABLE 306            HOYA CORPORATION: COMPANY OVERVIEW                 262

TABLE 307            HOYA CORPORATION: PRODUCTS OFFERED                 263

TABLE 308            HOYA CORPORATION: DEALS, JANUARY 2022–JULY 2025             265

TABLE 309            CONMED CORPORATION: COMPANY OVERVIEW          266

TABLE 310            CONMED CORPORATION: PRODUCTS OFFERED             268

TABLE 311            THE MIELE GROUP: COMPANY OVERVIEW                 269

TABLE 312            THE MIELE GROUP: PRODUCTS OFFERED                 269

TABLE 313            THE MIELE GROUP: DEALS, JANUARY 2022–JULY 2025        270

TABLE 314            ARC HEALTHCARE SOLUTIONS: COMPANY OVERVIEW          271

TABLE 315            ARC HEALTHCARE SOLUTIONS: PRODUCTS OFFERED             271

TABLE 316            METREX RESEARCH, LLC: COMPANY OVERVIEW                 273

TABLE 317            METREX RESEARCH, LLC: PRODUCTS OFFERED                 273

TABLE 318            MEDALKAN: COMPANY OVERVIEW         274

TABLE 319            MICRO-SCIENTIFIC, LLC: COMPANY OVERVIEW                 275

TABLE 320            ENDO-TECHNIK W. GRIESAT GMBH: COMPANY OVERVIEW          276

TABLE 321            BES HEALTHCARE LTD: COMPANY OVERVIEW                 277

TABLE 322            FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW   278

TABLE 323            BORER CHEMIE AG: COMPANY OVERVIEW                 279

TABLE 324            MEDONICA CO. LTD: COMPANY OVERVIEW                 280

TABLE 325            TUTTNAUER: COMPANY OVERVIEW      281

TABLE 326            SHINVA MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW   282

TABLE 327            SBSYSTEM: COMPANY OVERVIEW            283

TABLE 328            OLIVE HEALTH CARE: COMPANY OVERVIEW                 284

TABLE 329            MMM GROUP: COMPANY OVERVIEW     285

TABLE 330            AMITY INTERNATIONAL: COMPANY OVERVIEW                 286

TABLE 331            MİXTA MEDİKAL: COMPANY OVERVIEW                 287

TABLE 332            MEDICAL DEVICES GROUP SRL: COMPANY OVERVIEW          288

LIST OF FIGURES

FIGURE 1              ENDOSCOPE REPROCESSING MARKET SEGMENTATION AND REGIONAL SCOPE              29

FIGURE 2              ENDOSCOPE REPROCESSING MARKET: YEARS CONSIDERED    30

FIGURE 3              ENDOSCOPE REPROCESSING MARKET: RESEARCH DESIGN         33

FIGURE 4              ENDOSCOPE REPROCESSING MARKET: KEY DATA FROM SECONDARY SOURCES        35

FIGURE 5              ENDOSCOPE REPROCESSING MARKET: KEY PRIMARY SOURCES         36

FIGURE 6              ENDOSCOPE REPROCESSING MARKET: KEY INDUSTRY INSIGHTS     38

FIGURE 7              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS     38

FIGURE 8              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     39

FIGURE 9              ENDOSCOPE REPROCESSING MARKET: COMPANY REVENUE ESTIMATION, 2024                40

FIGURE 10            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 41

FIGURE 11            ENDOSCOPE REPROCESSING MARKET: TOP-DOWN APPROACH          42

FIGURE 12            ENDOSCOPE REPROCESSING MARKET: DATA TRIANGULATION             43

FIGURE 13            ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,

2025 VS. 2030 (USD MILLION)      46

FIGURE 14            ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE,

2025 VS. 2030 (USD MILLION)      47

FIGURE 15            ENDOSCOPE REPROCESSING MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      48

FIGURE 16            GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET              49

FIGURE 17            INCREASING VOLUME OF ENDOSCOPIC PROCEDURES TO DRIVE MARKET            50

FIGURE 18            ENDOSCOPE REPROCESSING CONSUMABLES SEGMENT AND JAPAN LED

ASIA PACIFIC MARKET IN 2024   51

FIGURE 19            GERMANY TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030              52

FIGURE 20            ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD       53

FIGURE 21            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD  54

FIGURE 22            ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 55

FIGURE 23            NEW REVENUE POCKETS FOR PLAYERS IN ENDOSCOPE REPROCESSING MARKET  65

FIGURE 24            ENDOSCOPE REPROCESSING MARKET: VALUE CHAIN ANALYSIS              67

FIGURE 25            ENDOSCOPE REPROCESSING MARKET: SUPPLY CHAIN ANALYSIS              69

FIGURE 26            ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS  70

FIGURE 27            ENDOSCOPE REPROCESSING MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2025          71

FIGURE 28            ENDOSCOPE REPROCESSING MARKET: PATENT ANALYSIS,

JANUARY 2015–DECEMBER 2024 73

FIGURE 29            ENDOSCOPE REPROCESSING MARKET: PORTER’S FIVE FORCES ANALYSIS           82

FIGURE 30            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER               84

FIGURE 31            KEY BUYING CRITERIA, BY END USER    84

FIGURE 32            KEY AI USE CASES IN ENDOSCOPE REPROCESSING MARKET              86

FIGURE 33            NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT       152

FIGURE 34            ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT       188

FIGURE 35            REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET, 2020–2024              227

FIGURE 36            MARKET SHARE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET, 2024        228

FIGURE 37            EV/EBITDA OF KEY VENDORS, 2025         230

FIGURE 38            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS, 2025 230

FIGURE 39            ENDOSCOPE REPROCESSING MARKET: BRAND/PRODUCT COMPARISON             231

FIGURE 40            ENDOSCOPE REPROCESSING MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       232

FIGURE 41            ENDOSCOPE REPROCESSING MARKET: COMPANY FOOTPRINT 233

FIGURE 42            ENDOSCOPE REPROCESSING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 236

FIGURE 43            STERIS: COMPANY SNAPSHOT (2025)      242

FIGURE 44            ASP: COMPANY SNAPSHOT (2024)             248

FIGURE 45            OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)             251

FIGURE 46            GETINGE AB: COMPANY SNAPSHOT (2024)                 256

FIGURE 47            ECOLAB INC.: COMPANY SNAPSHOT (2024)                 260

FIGURE 48            HOYA CORPORATION: COMPANY SNAPSHOT (2025)    263

FIGURE 49            CONMED CORPORATION: COMPANY SNAPSHOT (2024)             267